Allergan (AGN)

Drug company Allergen said its third-quarter earnings increased to $179 million, or 58 cents per share, from $165 million, or 54 cents per share, in the year-earlier period. The company said global sales rose 4.2 percent to $1.13 billion in the quarter, topping analysts' expectations of $1.08 billion
Results were helped by rebound in Botox sales.

Oct 29 · 1:36:00 PM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter